Small-molecule mediated neuroprotection in an in situ model of tauopathy. - Wikidata - wikimedia - TriplyDB

Small-molecule mediated neuroprotection in an in situ model of tauopathy.

Small-molecule mediated neuroprotection in an in situ model of tauopathy.

http://www.wikidata.org/entity/Q37087223

about

Is tau ready for admission to the prion club?Tangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing Problem The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics Ligand electronic properties modulate tau filament binding site density Structure-activity relationship of cyanine tau aggregation inhibitors.Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer's disease.QSAR studies for prediction of cross-β sheet aggregate binding affinity and selectivity Are tau aggregates toxic or protective in tauopathies?Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model.

P2860

Q24630925-92B5C8A7-884E-412B-80C6-122B7B8BF060 Q27004724-D86CC5DD-5C5E-48EF-B378-7F82935FB9BB Q35216140-32F0DEBF-C18A-4897-B2B5-3EA0A5491F34 Q36368413-7CCE9473-1FDA-41A1-9EFA-21E202755667 Q37349368-F80BD261-6C61-404A-B169-B4760257FD57 Q39005823-5471B2A9-5402-4023-9F24-F65D0DCA079A Q40998017-7D3B8647-06F9-402E-98D1-C2BFB0C23ED9 Q42024199-F8E3F845-7385-4663-8433-E010CEDB207E Q43103264-578AE5E6-037F-4D78-A883-5079A5C72CAB

P2860

Small-molecule mediated neuroprotection in an in situ model of tauopathy.

http://www.wikidata.org/entity/Q37087223

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Small-molecule mediated neuroprotection in an in situ model of tauopathy.

@en

Small-molecule mediated neuroprotection in an in situ model of tauopathy.

@nl

type

label

Small-molecule mediated neuroprotection in an in situ model of tauopathy.

@en

Small-molecule mediated neuroprotection in an in situ model of tauopathy.

@nl

prefLabel

Small-molecule mediated neuroprotection in an in situ model of tauopathy.

@en

Small-molecule mediated neuroprotection in an in situ model of tauopathy.

@nl

P1433

Q37087223-0ADD7ADC-E5F1-4CD7-89B9-45ED67C0E2AA

P1476

Q37087223-35EAF455-81B0-470E-A682-90A9C728D009

P2093

Q37087223-1B78EE27-18AE-448C-B4A9-5DCDB9CF05EB

Q37087223-4E79D3B5-D244-49F7-A7B0-C669D82A0C22

Q37087223-60CE94C4-B303-4F1B-BC76-EFA59888E7CA

Q37087223-A0D3AE15-8293-44CB-B191-BE1AA1E7C0FE

Q37087223-C3E59F80-2E34-451C-8759-AF218827DF2C

P2860

Q37087223-0647A03E-E29B-497C-B219-427AAA24EDA9

Q37087223-0BA13AEB-8DBB-4B4B-B390-34BEF23B178D

Q37087223-24992796-59E0-47F5-A944-FE216BEA6A3F

Q37087223-2A45F89C-471F-454F-BD50-01DB0D5E4553

Q37087223-30AAD6C7-F928-4219-9EE1-F38BB495E1CB

Q37087223-36DC0270-8E51-4BD7-9D34-3345638C7338

Q37087223-37DE6E04-30DE-4B35-9F9B-BD41156246F5

Q37087223-3C0CE9ED-7727-403D-A146-E541AA94BB7A

Q37087223-41FF9D92-AAF9-4C3B-B728-9F6A8C06AF9A

Q37087223-4D5F763B-8101-44EC-8A87-37602B63B863

P2888

Q37087223-B76E6EF8-E19D-4949-8E30-AC4FC2726A8F

P304

Q37087223-8119DCC8-790E-4B22-84AB-E661045A6937

P31

Q37087223-3E444E0F-CBF4-4DBF-A2CB-65E9942048D6

P356

Q37087223-7792283A-DBC4-4992-8113-FF76ED936D04

P433

Q37087223-2CF7F321-075E-4C12-BB16-1D8971F1E74D

P478

Q37087223-65F53E32-EBF2-4687-99B6-D64683092281

P577

Q37087223-D5D3DB2F-2DCE-43EF-BCCA-7E03B10BA6AE

P5875

Q37087223-20593957-CA05-436D-9F3E-D7BE869379EC

P698

Q37087223-0DB3CC35-EDF9-40E8-AE2F-DC75BDBB9E88

P932

Q37087223-A3CF66A0-391E-496F-AD91-83D92FBFD1F8

P356

S12640-009-9028-Y

P1433

Neurotoxicity Research

P1476

Small-molecule mediated neuroprotection in an in situ model of tauopathy.

@en

P2093

Aida Abraha

http://www.w3.org/2001/XMLSchema#string

Garth F Hall

http://www.w3.org/2001/XMLSchema#string

Jeff Kuret

http://www.w3.org/2001/XMLSchema#string

Jordan R Jensen

http://www.w3.org/2001/XMLSchema#string

Nicolette S Honson

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer's disease: paired helical filaments and cytomembranes

Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy

Neurodegenerative tauopathies

Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay

The binding of thioflavin-T to amyloid fibrils: localisation and implications.

Differentiating Alzheimer disease-associated aggregates with small molecules.

A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo.

A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease.

A decade of tau transgenic animal models and beyond.

Tau aggregation and toxicity in tauopathic neurodegenerative diseases.

P2888

s12640-009-9028-y

P304

274-283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12640-009-9028-Y

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24346738

http://www.w3.org/2001/XMLSchema#string

P698

19384600

http://www.w3.org/2001/XMLSchema#string

P932

3740339

http://www.w3.org/2001/XMLSchema#string